Clinical Trials Directory

Trials / Unknown

UnknownNCT05011981

Hemostatic Activity Following LAAO

Hemostatic Activity Following Left Atrial Appendage Occlusion

Status
Unknown
Phase
Study type
Observational
Enrollment
135 (estimated)
Sponsor
University of Aarhus · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

The primary objective of this study is to prospectively investigate hemostatic activity following transcatheter left atrial appendage occlusion (LAAO).

Detailed description

This is a prospective cohort study of patients undergoing transcatheter LAAO at Aarhus University Hospital. Hemostatic consequences following device implantation will be evaluated using blood samples collected pre- and post-procedurally, and serially during three months follow-up in 135 LAAO patients. Platelet function and characteristics, overall activation of the extrinsic coagulation pathway and the intrinsic contact activation pathway, as well as endothelial response to implantation, will be assessed through a wide range of biochemical analyses. Patients will serve as their own controls, with a final control blood sample collected at three-months follow-up.

Conditions

Interventions

TypeNameDescription
DEVICELeft Atrial Appendage OcclusionInterventional left atrial appendage occlusion with the Amulet or Watchman device

Timeline

Start date
2021-10-11
Primary completion
2024-07-01
Completion
2024-12-01
First posted
2021-08-18
Last updated
2024-01-11

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT05011981. Inclusion in this directory is not an endorsement.